P2.01-33 Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1 Containing Therapy (HUDSON)
| Autor: | Forde, P., Heymach, J., Thomas, M., Park, K., Besse, B., Awad, M., Goss, G., Rizvi, N., Ambrose, H., Jewsbury, P., Koetz, B., Lao-Sirieix, S., Mortimer, P., Patel, S., Sachsenmeier, K., Brugger, W. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2018 13(10) Supplement:S677-S677 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|